# Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

> **NCT00707590** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 120 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** BMS-767778 or Placebo

## Key facts

- **NCT ID:** NCT00707590
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707590, "Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00707590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*